AstraZeneca announces new R&D, AI centres in China

AstraZeneca is planning to build a new global research and development centre in China.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

AstraZeneca partners on AI drug discovery collaboration

2 May 2019 AstraZeneca has begun collaborating with UK-headquartered artificial intelligence company BenevolentAI to use AI and machine learning for the discovery and development of new treatments.

Big Pharma

AstraZeneca and Daiichi Sankyo to jointly develop another new cancer treatment

30 July 2020 Biopharmaceutical company AstraZeneca has struck a deal with Japanese pharmaceutical company Daiichi Sankyo to jointly develop and market a new medicine to treat lung, breast and other cancers.

More on this story

Big Pharma

AstraZeneca partners on AI drug discovery collaboration

2 May 2019 AstraZeneca has begun collaborating with UK-headquartered artificial intelligence company BenevolentAI to use AI and machine learning for the discovery and development of new treatments.

Big Pharma

AstraZeneca and Daiichi Sankyo to jointly develop another new cancer treatment

More on this story

Big Pharma

AstraZeneca partners on AI drug discovery collaboration

2 May 2019 AstraZeneca has begun collaborating with UK-headquartered artificial intelligence company BenevolentAI to use AI and machine learning for the discovery and development of new treatments.

Big Pharma

AstraZeneca and Daiichi Sankyo to jointly develop another new cancer treatment